Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Freshmen Reps Join Early Effort To Kill Device Tax In New Congress

This article was originally published in The Gray Sheet

Executive Summary

Rep. Eric Paulsen, R-Minn., made a bid to repeal the medical device tax at the start of the new session in a bill that would be retroactive to the 2013 tax year and has attracted 253 cosponsors, including 26 Democrats.

You may also be interested in...



FDA Will Face Reforms, Oversight In Republican Congress, Analysts Say

Election gains by Republicans will embolden Congress to put FDA in its oversight “crosshairs,” as members of key Senate and House panels scrutinize how the agency is using its resources. Reforms could also come soon as part of the ongoing 21st Century Cures initiative.

News In Brief

Senate symbolically votes to repeal device tax. Sequester will take about 5 percent from device user fees. More news in brief.

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT033891

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel